Morphine and alternative opioids in cancer pain: the EAPC recommendations

Abstract

An expert working group of the European Association for Palliative Care has revised and updated its guidelines on the use of morphine in the management of cancer pain. The revised recommendations presented here give guidance on the use of morphine and the alternative strong opioid analgesics which have been introduced in many parts of the world in recent years. Practical strategies for dealing with difficult situations are described presenting a consensus view where supporting evidence is lacking. The strength of the evidence on which each recommendation is based is indicated.

References 31

1. 1.

   Bruera E., Belzile M., Pituskin E., Fainsinger R., Darke A., Harsanyi Z., Babul N., Ford I. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol. 1998;16(10):3222-3229.

   Not in our library10.1200/jco.1998.16.10.3222

2. 2.

   Chrubasik J., Wüst H., Friedrich G., Geller E. Absorption and bioavailability of nebulized morphine. Br J Anaesth. 1988;61(2):228-230.

   Not in our library10.1093/bja/61.2.228

3. 3.

   Collins S. L., Faura C. C., Moore R. A., McQuay H. J. Peak plasma concentrations after oral morphine: a systematic review. J Pain Symptom Manage. 1998;16(6):388-402.

   Not in our library10.1016/s0885-3924(98)00094-3

4. 4.

   De Conno F., Groff L., Brunelli C., Zecca E., Ventafridda V., Ripamonti C. Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. J Clin Oncol. 1996;14(10):2836-2842.

   Not in our library10.1200/jco.1996.14.10.2836

5. 5.

   Dover S. B. Syringe driver in terminal care. Br Med J (Clin Res Ed). 1987;294(6571):553-555.

   Not in our library10.1136/bmj.294.6571.553

6. 6.

   Eisenach J. C., DuPen S., Dubois M., Miguel R., Allin D. Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group. Pain. 1995;61(3):391-399.

   Not in our library10.1016/0304-3959(94)00209-w

7. 7.

   Glare P. A., Walsh T. D. Clinical pharmacokinetics of morphine. Ther Drug Monit. 1991;13(1):1-23.

   Not in our library10.1097/00007691-199101000-00001

8. 8.

   Gourlay G. K., Cherry D. A., Onley M. M., Tordoff S. G., Conn D. A., Hood G. M., Plummer J. L. Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain. Pain. 1997;69(3):295-302.

   Not in our library10.1016/s0304-3959(96)03269-1

9. 9.

   Hanks G. W., Hoskin P. J., Aherne G. W., Turner P., Poulain P. Explanation for potency of repeated oral doses of morphine? Lancet. 1987;2(8561):723-725.

   Not in our library10.1016/s0140-6736(87)91083-x

10. 10.

    Hanks G. W. Opioid-responsive and opioid-non-responsive pain in cancer. Br Med Bull. 1991;47(3):718-731.

    Not in our library10.1093/oxfordjournals.bmb.a072503

11. 11.

    Hoskin P. J., Hanks G. W., Aherne G. W., Chapman D., Littleton P., Filshie J. The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers. Br J Clin Pharmacol. 1989;27(4):499-505.

    Not in our library10.1111/j.1365-2125.1989.tb05399.x

12. 12.

    Jadad A. R., Browman G. P. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA. 1995;274(23):1870-1873.

    Not in our library

13. 13.

    Kaiko R. F. The therapeutic equivalence of i.m. and p.o. administration of morphine--1:3 or 1:6? J Palliat Care. 1988;4(1-2):64-66.

    Not in our library

14. 14.

    Kalso E., Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther. 1990;47(5):639-646.

    Not in our library10.1038/clpt.1990.85

15. 15.

    Lehmann K. A., Zech D. Transdermal fentanyl: clinical pharmacology. J Pain Symptom Manage. 1992;7(3 Suppl):S8-16.

    Not in our library10.1016/0885-3924(92)90048-m

16. 16.

    McQuay H. Opioids in pain management. Lancet. 1999;353(9171):2229-2232.

    Not in our library10.1016/s0140-6736(99)03528-x

17. 17.

    Megens A. A., Artois K., Vermeire J., Meert T., Awouters F. H. Comparison of the analgesic and intestinal effects of fentanyl and morphine in rats. J Pain Symptom Manage. 1998;15(4):253-257.

    Not in our library10.1016/s0885-3924(97)00371-0

18. 18.

    Mercadante S. Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home. Cancer. 1999;85(8):1849-1858.

    Not in our library10.1002/(sici)1097-0142(19990415)85:8<1849::aid-cncr27>3.0.co;2-6

19. 19.

    Mercadante S. Problems of long-term spinal opioid treatment in advanced cancer patients. Pain. 1999;79(1):1-13.

    Not in our library10.1016/s0304-3959(98)00118-3

20. 20.

    Moulin D. E., Kreeft J. H., Murray-Parsons N., Bouquillon A. I. Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. Lancet. 1991;337(8739):465-468.

    Not in our library10.1016/0140-6736(91)93401-t

21. 21.

    Plummer J. L., Gourlay G. K., Cherry D. A., Cousins M. J. Estimation of methadone clearance: application in the management of cancer pain. Pain. 1988;33(3):313-322.

    Not in our library10.1016/0304-3959(88)90290-4

22. 22.

    Portenoy R. K., Hagen N. A. Breakthrough pain: definition, prevalence and characteristics. Pain. 1990;41(3):273-281.

    Not in our library10.1016/0304-3959(90)90004-w

23. 23.

    Portenoy R. K., Payne R., Coluzzi P., Raschko J. W., Lyss A., Busch M. A., Frigerio V., Ingham J., Loseth D. B., Nordbrock E. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. Pain. 1999;79(2-3):303-312.

    Not in our library10.1016/s0304-3959(98)00179-1

24. 24.

    Ripamonti C., Bruera E. Rectal, buccal, and sublingual narcotics for the management of cancer pain. J Palliat Care. 1991;7(1):30-35.

    Not in our library

25. 25.

    Ripamonti C., Groff L., Brunelli C., Polastri D., Stavrakis A., De Conno F. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol. 1998;16(10):3216-3221.

    Not in our library10.1200/jco.1998.16.10.3216

26. 26.

    Säwe J., Dahlström B., Rane A. Steady-state kinetics and analgesic effect of oral morphine in cancer patients. Eur J Clin Pharmacol. 1983;24(4):537-542.

    Not in our library10.1007/bf00609900

27. 27.

    Säwe J. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment. Clin Pharmacokinet. 1986;11(2):87-106.

    Not in our library10.2165/00003088-198611020-00001

28. 28.

    Twycross R. G. Control of pain. J R Coll Physicians Lond. 1984;18(1):32-39.

    Not in our library

29. 29.

    Twycross R. G. The therapeutic equivalence of oral and subcutaneous/intramuscular morphine sulphate in cancer patients. J Palliat Care. 1988;4(1-2):67-68.

    Not in our library

30. 30.

    Vainio A., Ollila J., Matikainen E., Rosenberg P., Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet. 1995;346(8976):667-670.

    Not in our library10.1016/s0140-6736(95)92281-4

31. 31.

    de Stoutz N. D., Bruera E., Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage. 1995;10(5):378-384.

    Not in our library10.1016/0885-3924(95)90924-c

Cited by papers we hold 4

• Opioid Use at End-Of-Life Among Nova Scotia Patients With Cancer · 2022
  Not checked
• Clinical Management of Pain in Advanced Lung Cancer · 2012
  Not checked
• Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group · 2009
  No notice
• Knowledge toward Cancer Pain and the Use of Opioid Analgesics among Medical Students in their Integrated Clinical Clerkship · 2008
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.